Furthermore, researchers have demonstrated that PCa markers, such as PSA, PSMA (prostate-specific membrane antigen), and 5T4 (oncofetal glycoprotein), are differentially positive in urinary EVs from cancer patients compared to healthy volunteers. This evidence concerns the gene FOLH1 and cancer.